IO Biotech Inc. (IOBT)
NASDAQ: IOBT
· Real-Time Price · USD
1.88
-0.17 (-8.29%)
At close: Aug 20, 2025, 3:59 PM
1.96
4.26%
Pre-market: Aug 21, 2025, 05:43 AM EDT
-8.29% (1D)
| Bid | 1.81 |
| Market Cap | 123.86M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -98.45M |
| EPS (ttm) | -1.58 |
| PE Ratio (ttm) | -1.19 |
| Forward PE | -1.95 |
| Analyst | Buy |
| Ask | 1.91 |
| Volume | 1,983,538 |
| Avg. Volume (20D) | 2,942,191 |
| Open | 2.05 |
| Previous Close | 2.05 |
| Day's Range | 1.86 - 2.06 |
| 52-Week Range | 0.66 - 2.79 |
| Beta | 0.44 |
About IOBT
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol IOBT
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for IOBT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts6 days ago
+68.75%
IO Biotech shares are trading higher following the...
Unlock content with
Pro Subscription
1 week ago
-41.99%
Shares are trading lower after the company said its Phase 3 trial of Cylembio plus Keytruda in advanced melanoma narrowly missed the primary endpoint.
